tiprankstipranks
Austar Lifesciences Ltd. (HK:6118)
HKEX:6118
Hong Kong Market

Austar Lifesciences Ltd. (6118) Stock Price & Analysis

0 Followers

6118 Stock Chart & Stats

Day’s RangeHK$0 - HK$0
52-Week RangeHK$0.55 - HK$3.18
Previous CloseHK$0.66
Volume41.00K
Average Volume (3M)288.39K
Market Cap
HK$338.30M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)
Beta0.34
Aug 26, 2024
EPS EstimateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.24
Shares Outstanding512,582,000
10 Day Avg. Volume324,100
30 Day Avg. Volume288,392
Standard Deviation0.12
R-Squared0.02
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

6118 FAQ

What was Austar Lifesciences Ltd.’s price range in the past 12 months?
Austar Lifesciences Ltd. lowest stock price was HK$0.55 and its highest was HK$3.18 in the past 12 months.
    What is Austar Lifesciences Ltd.’s market cap?
    Currently, no data Available
    When is Austar Lifesciences Ltd.’s upcoming earnings report date?
    Austar Lifesciences Ltd.’s upcoming earnings report date is Aug 26, 2024 which is in 36 days.
      How were Austar Lifesciences Ltd.’s earnings last quarter?
      Austar Lifesciences Ltd. released its earnings results on Mar 26, 2024. The company reported -HK$0.155 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.155.
        Is Austar Lifesciences Ltd. overvalued?
        According to Wall Street analysts Austar Lifesciences Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Austar Lifesciences Ltd. pay dividends?
          Austar Lifesciences Ltd. pays a Notavailable dividend of HK$0.05 which represents an annual dividend yield of N/A. See more information on Austar Lifesciences Ltd. dividends here
            What is Austar Lifesciences Ltd.’s EPS estimate?
            Austar Lifesciences Ltd.’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Austar Lifesciences Ltd. have?
            Austar Lifesciences Ltd. has 512,582,030 shares outstanding.
              What happened to Austar Lifesciences Ltd.’s price movement after its last earnings report?
              Austar Lifesciences Ltd. reported an EPS of -HK$0.155 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 0.806%.
                Which hedge fund is a major shareholder of Austar Lifesciences Ltd.?
                Currently, no hedge funds are holding shares in HK:6118
                ---

                Austar Lifesciences Ltd. Stock Smart Score

                10
                Unlock Smart Score
                1
                2
                3
                4
                5
                6
                7
                8
                9
                10

                Technicals

                SMA
                Negative
                20 days / 200 days
                Momentum
                -70.00%
                12-Months-Change

                Fundamentals

                Return on Equity
                -4.01%
                Trailing 12-Months
                Asset Growth
                -11.37%
                Trailing 12-Months

                Company Description

                Austar Lifesciences Ltd.

                Austar Lifesciences Ltd is a China-based company engaged in providing engineering solutions to pharmaceutical manufacturers and research institutes. The business activity of the group is operated through Liquid and Bioprocess System; Clean Room and Automation Control and Monitoring System; Powder and Solid System; Good Manufacturing Practice (GMP) Compliance Service; Life Science Consumables; and Distribution and Agency of Pharmaceutical Equipment segments. It derives the majority of revenue from the Liquid and Bioprocess System segment which is involved in providing solutions in pharmaceutical and water systems to treat water. The geographical business presence of the firm is seen across China and in other countries.
                ---
                Similar Stocks
                Company
                Price & Change
                Follow
                Topsports International Holdings Limited
                Rizhao Port Jurong Co. Ltd. Class H
                Qingdao Port International Co Ltd Class H
                UTS Marketing Solutions Holdings Ltd.
                Popular Stocks
                ---
                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis